Screener
Prime Medicine PRME Business Segments — Total other income, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Facility related | 10,577 | 13,765 | 20,843 | 24,734 |
| Research costs | 6,158 | 8,116 | 13,418 | 19,152 |
| General and administrative expenses: | ||||
| Personnel expenses | 5,559 | 7,082 | 11,091 | 14,238 |
| Other segment items (1) | 11,345 | 11,081 | 28,744 | 20,966 |
| Total operating expenses | 44,439 | 54,492 | 95,949 | 108,338 |
| Total other income, net | 1,176 | 786 | 2,708 | 1,288 |
| Net loss | $(42,109) | $(52,591) | $(91,231) | $(104,481) |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's business segments — total other income, net?
- Prime Medicine (PRME) reported business segments — total other income, net of $1.18M in Q2 2026.
- How has Prime Medicine's business segments — total other income, net changed year-over-year?
- Prime Medicine's business segments — total other income, net increased by 49.6% year-over-year, from $786K to $1.18M.
- What is the long-term trend for Prime Medicine's business segments — total other income, net?
- Over 2 years (2023 to 2025), Prime Medicine's business segments — total other income, net has grown at a 6.3% compound annual growth rate (CAGR), from $6.38M to $7.21M.
- What does business segments — total other income, net mean?
- Reflects the net balance of income and expenses generated by a business segment that are outside of its primary operating activities, such as interest income or minor non-operating gains. This metric helps isolate the impact of non-core financial activities on the segment's overall financial performance. It provides context on the segment's ability to generate supplemental cash flows.
Ask your AI about Prime Medicine's business segments — total other income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude